Cited by 412Complement system in diseasesAntimicrobial Peptides and ActivitiesImmune Response and Inflammation

Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability

Open access
Wu, Huixing, Kuzmenko, Alexander, Wan, Sijue, Schaffer, Lyndsay, Weiss, Alison, Fisher, James H., Kim, Kwang Sik, McCormack, Francis X.·2003·Journal of Clinical Investigation

Abstract

The pulmonary collectins, surfactant proteins A (SP-A) and D (SP-D), have been reported to bind lipopolysaccharide (LPS), opsonize microorganisms, and enhance the clearance of lung pathogens. In this study, we examined the effect of SP-A and SP-D on the growth and viability of Gram-negative bacteria. The pulmonary clearance of Escherichia coli K12 was reduced in SP-A-null mice and was increased in SP-D-overexpressing mice, compared with strain-matched wild-type controls. Purified SP-A and SP-D inhibited bacterial synthetic functions of several, but not all, strains of E. coli, Klebsiella pneumoniae, and Enterobacter aerogenes. In general, rough E. coli strains were more susceptible than smooth strains, and collectin-mediated growth inhibition was partially blocked by coincubation with rough LPS vesicles. Although both SP-A and SP-D agglutinated E. coli K12 in a calcium-dependent manner, microbial growth inhibition was independent of bacterial aggregation. At least part of the antimicrobial activity of SP-A and SP-D was localized to their C-terminal domains using truncated recombinant proteins. Incubation of E. coli K12 with SP-A or SP-D increased bacterial permeability. Deletion of the E. coli OmpA gene from a collectin-resistant smooth E. coli strain enhanced SP-A and SP-D-mediated growth inhibition. These data indicate that SP-A and SP-D are antimicrobial proteins that directly inhibit the proliferation of Gram-negative bacteria in a macrophage- and aggregation-independent manner by increasing the permeability of the microbial cell membrane.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci16889

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inactivation of alveolar surfactant decreases the elimination of surfactant-sensitive bacteria.

    “The inactivation of alveolar surfactant decreases the elimination of surfactant-sensitive bacteria.”

    From The microbiome and critical illness (2016) · cites this paper as [57]

  • In alveolar injury, the bactericidal surfactant layer is inactivated and microbial elimination is slowed by impairment of mucociliary clearance.

    “The bactericidal surfactant layer is inactivated55,57 and microbial elimination is slowed by impairment of mucociliary clearance.”

    From The microbiome and critical illness (2016) · cites this paper as [57]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wu, H., Kuzmenko, A., Wan, S., Schaffer, L., Weiss, A., Fisher, J. H., Kim, K. S., & McCormack, F. X.
Affiliations
  • University of Cincinnati (US)
  • University of Colorado Denver (US)
  • Johns Hopkins University (US)
Venue
Journal of Clinical Investigation
Published
2003-05-15
Volume
111
Issue
10
Pages
1589-1602
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2128714994
Cited by
412
References
68
Citations by year
2026: 4 · 2025: 13 · 2024: 12 · 2023: 8 · 2022: 13 · 2021: 25 · 2020: 19 · 2019: 15 · 2018: 14 · 2017: 18 · 2016: 12 · 2015: 24 · 2014: 12 · 2013: 15 · 2012: 21
FWCI
10.27
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL61612, R01HL061612)
  • National Institute of Environmental Health Sciences (P30ES-0609606)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
surfactant protein A, surfactant protein D, Gram-negative bacteria, bacterial growth inhibition, membrane permeability, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, lipopolysaccharide, OmpA, antimicrobial activity, bacterial clearance, C-terminal domain
MeSH terms
Animals, Bacterial Outer Membrane Proteins, Bronchoalveolar Lavage Fluid, Cell Division, Cell Membrane Permeability, Dactinomycin, Escherichia coli, Escherichia coli Infections, Fluorescent Dyes, Gram-Negative Bacteria, Humans, Mice, Inbred C3H, Microbial Sensitivity Tests, Respiratory Tract Infections, Rats, Sprague-Dawley, Mice, Knockout, Genetic Predisposition to Disease, Collectins, Pulmonary Surfactant-Associated Protein A, Pulmonary Surfactant-Associated Protein D, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review